AstraZeneca drug discount card?
Executive Summary
AstraZeneca may consider offering senior drug discount card if the Bush Administration's proposal does not materialize and industry does not come to an agreement on a collective card program, North America President David Brennan told analysts Jan. 31. Pfizer briefed the Pharmaceutical Research & Manufacturers of America on its "Share Card" program in an effort to encourage other companies to sign on (1"The Pink Sheet" Jan. 28, p. 27)...
You may also be interested in...
Pfizer “Share Card” Reaches 10% Of 1 Mil. Enrollee Goal In First Week
Pfizer is approximately 10% of the way to its goal of enrolling 1 mil. participants in the "Share Card" program this year
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.